Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Covington
Harvard Business School
McKesson
Fuji
Cerilliant
Chinese Patent Office
Healthtrust
Colorcon
Baxter

Generated: October 17, 2017

DrugPatentWatch Database Preview

Mafenide acetate - Generic Drug Details

« Back to Dashboard

What are the generic sources for mafenide acetate and what is the scope of mafenide acetate patent protection?

Mafenide acetate
is the generic ingredient in two branded drugs marketed by Par Form, Novast Labs Ltd, and Mylan Institutional, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for mafenide acetate. Three suppliers are listed for this compound.

Summary for Generic Name: mafenide acetate

US Patents:0
Tradenames:2
Applicants:3
NDAs:4
Drug Master File Entries: see list3
Suppliers / Packagers: see list3
Bulk Api Vendors: see list53
Clinical Trials: see list926
Patent Applications: see list707
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:mafenide acetate at DailyMed

Pharmacology for Ingredient: mafenide acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Institutional
SULFAMYLON
mafenide acetate
FOR SOLUTION;TOPICAL019832-003Jun 5, 1998ATRXYesYes► Subscribe► Subscribe► Subscribe
Novast Labs Ltd
MAFENIDE ACETATE
mafenide acetate
FOR SOLUTION;TOPICAL206716-001Jul 31, 2017ATRXNoNo► Subscribe► Subscribe► Subscribe
Par Form
MAFENIDE ACETATE
mafenide acetate
FOR SOLUTION;TOPICAL201511-001Feb 12, 2013ATRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Institutional
SULFAMYLON
mafenide acetate
CREAM;TOPICAL016763-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: mafenide acetate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Institutional
SULFAMYLON
mafenide acetate
CREAM;TOPICAL016763-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
US Army
McKinsey
Colorcon
Express Scripts
Cipla
Chinese Patent Office
Farmers Insurance
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot